BTLA Recombinant Protein

• Background:

  B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.

• Swiss Prot:

  Q32MV9

• Accession Number:

  Q32MV9

• Tag:

  His Tag

• Type:

  Recombinant Proteins

• Source:

  HEK293 cells

• Field of Research:

  Immunology

• Buffer:

  PBS, pH7.4

• Shipping Conditions:

  Room Temp

• Storage Conditions:

  Lyophilized Protein should be stored at -20˚ C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚ C or -70˚ C. Avoid repeated freeze-thaw cycles.

• Calculated Molecular Weight:

  18.6 kDa

• Applications Notes:

  This recombinant protein can be used for E, WB. For research use only.

• NCBI Official Name:

  Btla protein

• NCBI Organism:

  Mus musculus

• Background Reference 01:

  Watanabe N., et al., 2003, Nat. Immunol. 4:670-679.

• Background Reference 02:

  Gavrieli M., et al., 2003, Biochem. Biophys. Res. Commun. 312:1236-1243.

• Background Reference 03:

  Sedy J.R., et al., 2005, Nat. Immunol. 6:90-98.

• Other Product Names:

  BTLA, CD272

• Tested Applications:

  ELISA, WB

• Species:

  Mouse

• Physical Properties:

  Lyophilized

• CAS Number:

  9000-83-3